Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2018 2
2019 1
2020 4
2021 5
2022 8
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Scleral Thickness in Simple Versus Complex Central Serous Chorioretinopathy.
Imanaga N, Terao N, Wakugawa S, Miyara Y, Sawaguchi S, Oshiro A, Yamauchi Y, Koizumi H. Imanaga N, et al. Among authors: terao n. Am J Ophthalmol. 2024 May;261:103-111. doi: 10.1016/j.ajo.2024.01.025. Epub 2024 Jan 26. Am J Ophthalmol. 2024. PMID: 38281567 Free article.
Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degeneration.
Kataoka K, Itagaki K, Hashiya N, Wakugawa S, Tanaka K, Nakayama M, Yamamoto A, Mukai R, Honjyo J, Maruko I, Kawai M, Miyara Y, Terao N, Wakatsuki Y, Onoe H, Mori R, Koizumi H, Sekiryu T, Iida T, Okada AA; for Japan AMD Research Consortium (JARC). Kataoka K, et al. Among authors: terao n. Graefes Arch Clin Exp Ophthalmol. 2024 Jan;262(1):43-51. doi: 10.1007/s00417-023-06222-x. Epub 2023 Sep 5. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 37668741
Three-month outcomes of faricimab loading therapy for wet age-related macular degeneration in Japan.
Mukai R, Kataoka K, Tanaka K, Miyara Y, Maruko I, Nakayama M, Watanabe Y, Yamamoto A, Wakatsuki Y, Onoe H, Wakugawa S, Terao N, Hasegawa T, Hashiya N, Kawai M, Maruko R, Itagaki K, Honjo J, Okada AA, Mori R, Koizumi H, Iida T, Sekiryu T. Mukai R, et al. Among authors: terao n. Sci Rep. 2023 May 30;13(1):8747. doi: 10.1038/s41598-023-35759-4. Sci Rep. 2023. PMID: 37253802 Free PMC article.
Reply to Marino et al. Does Subretinal Fluid Influence Choroidal Thickness (ChT) and Structure in Preeclampsia with Serous Retinal Detachment? Comment on "Fukui et al. Changes in Choroidal Thickness and Structure in Preeclampsia with Serous Retinal Detachment. J. Clin. Med. 2023, 12, 609".
Fukui A, Tanaka H, Terao N, Nagata K, Matsumoto A, Kusada N, Kojima K, Sotozono C. Fukui A, et al. Among authors: terao n. J Clin Med. 2023 May 4;12(9):3274. doi: 10.3390/jcm12093274. J Clin Med. 2023. PMID: 37176714 Free PMC article.
Scleral Thickness in Steroid-Induced Central Serous Chorioretinopathy.
Sawaguchi S, Terao N, Imanaga N, Wakugawa S, Tamashiro T, Yamauchi Y, Koizumi H. Sawaguchi S, et al. Among authors: terao n. Ophthalmol Sci. 2022 Feb 8;2(2):100124. doi: 10.1016/j.xops.2022.100124. eCollection 2022 Jun. Ophthalmol Sci. 2022. PMID: 36249703 Free PMC article.
26 results